SCHEMBL20788435

SCHEMBL20788435

CC(C)(C)OC(=O)N1C[C@H]2CC(Cc3ccc(Cl)cc3)C[C@@H]2C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.59
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ KCNK3 O14649 1/20 0.46
▸ KCNK9 Q9NPC2 1/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.45
▸ JAK2 O60674 1/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ VEGFA P15692 1/20 0.43
▸ EGLN1 Q9GZT9 1/20 0.43
▸ CNR1 P21554 1/20 0.43
▸ STS P08842 2/20 0.43
▸ USP30 Q70CQ3 1/20 0.43
▸ NR1D1 P20393 2/20 0.42
▸ NAMPT P43490 1/20 0.42
▸ USP2 O75604 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20788434 1.00 NR1H2 (0.59) NR1H2MEN1KMT2AKCNK3KCNK9
SCHEMBL20788437 1.00 NR1H2 (0.59) NR1H2MEN1KMT2AKCNK3KCNK9
SCHEMBL5220425 0.90 MEN1 (0.50) NR1H2MEN1KMT2AKCNK3KCNK9
SCHEMBL29716428 0.85 NR1H2 (0.56) NR1H2JAK2JAK1STSNAMPT
SCHEMBL24622416 0.85 NR1H2 (0.56) NR1H2JAK2JAK1NAMPT
SCHEMBL21276170 0.82 KCNK3 (0.59) NR1H2MEN1KMT2AKCNK3KCNK9
SCHEMBL3155704 0.82 STS (0.56) MEN1KMT2ANPSR1HTTSMN1; SMN2
SCHEMBL24267356 0.81 NR1H2 (0.49) NR1H2JAK2JAK1CNR1
SCHEMBL22036273 0.81 MEN1 (0.53) MEN1KMT2ANPSR1HTTSMN1; SMN2
SCHEMBL5870742 0.80 CHRM2 (0.52) MEN1KMT2AKCNK3KCNK9NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681883-B1 DIPHENYL DERIVATIVES AND USES THEREOF NOVARTIS AG (CH) 2024-02-21 — — EP disclosed
US-10633350-B2 Diphenyl derivatives and uses thereof NOVARTIS AG (CH) 2020-04-28 — — US disclosed
US-20190077773-A1 DIPHENYL DERIVATIVES AND USES THEREOF NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2019-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077773-A1 DIPHENYL DERIVATIVES AND USES THEREOF MYOF, NGF, MUSK NR1H2 4295/4885MEN1 4366/4885KMT2A 4503/4885
US-10633350-B2 Diphenyl derivatives and uses thereof MYOF, NGF, MUSK NR1H2 4295/4885MEN1 4366/4885KMT2A 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback